- ￥164 - 396
- TargetMol
- T1281
- 2026年07月07日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
AI 赋能培养基定制开发：CHO 培养基是如何实现产量提升Cytoscape 教程来了！快速实现顶刊同款通路网络图五大应用案例：Mustang Q 膜层析应用全解析1 个小工具，一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- CAS号：
1508-75-4
- 规格：
1mLx10mM(inDMSO)/25mg/50mg/100mg/200mg
| 规格： | 1mLx10mM(inDMSO) | 产品价格： | ￥329.0 |
|---|---|---|---|
| 规格： | 25mg | 产品价格： | ￥164.0 |
| 规格： | 50mg | 产品价格： | ￥233.0 |
| 规格： | 100mg | 产品价格： | ￥299.0 |
| 规格： | 200mg | 产品价格： | ￥396.0 |
Product Introduction
Bioactivity
| 名称 | Tropicamide |
| 描述 | Tropicamide (Ro 1-7683) is a synthetic muscarinic antagonist with actions similar to atropine and with an anticholinergic property. Upon ocular administration, tropicamide binds to and blocks the muscarinic receptors in the sphincter and ciliary muscle in the eye. This inhibits the responses from cholinergic stimulation, producing dilation of the pupil and paralysis of the ciliary muscle. Tropicamide is a diagnostic agent and is used to produce short-duration mydriasis and cycloplegia. |
| 体外活性 | 0.5％ Nepafenac明显抑制（46％）血-视网膜屏障破坏,导致视网膜水肿减少65％,且几乎完全抑制PGE2合成（96％）.Nepafenac在眼部的生物利用度明显更大. Nepafenac对COX-1的抑制活性较弱（IC50：64.3 μM）.在兔中,Nepafenac抑制视网膜/脉络膜（55％）和虹膜/睫状体（85-95％）中前列腺素的合成.和对照组小鼠相比,Nepafenac使脉络膜新生血管和缺血引起视网膜新生血管明显减少.Nepafenac也使缺血诱导的视网膜VEGF mRNA表达增加减缓.在眼和转移性动物模型中,Nepafenac延缓恶性肿瘤进程并减少葡萄膜黑色素瘤重量.在胰岛素不足型糖尿病大鼠的视网膜微血管内,Nepafenac对视网膜前列腺素E（2）,超氧化物,环氧合酶2和白细胞停滞均有显著抑制作用,但对血管内皮生长因子和一氧化氮无影响.在糖尿病大鼠中,Nepafenac明显抑制转移酶介导的dUTP缺口末端标记阳性毛细管细胞、周细胞和无细胞的毛细血管的数目. |
| 存储条件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (7.03 mM), Sonication is recommended. DMSO : 60 mg/mL (211.01 mM), Sonication is recommended. Ethanol : 53 mg/mL (186.39 mM), Sonication is recommended. |
| 关键字 | Tropicamide | pupil | mydriasis | Muscarinic acetylcholine receptor | muscarinic | mAChR | M4 mAChR | Inhibitor | inhibit | dilation | cycloplegia | acetylcholine |
| 相关产品 | Mitotane | Hexamethonium Bromide | Ethyl (triphenylphosphoranylidene) acetate | Urethane | Levamisole hydrochloride | Arecoline | Choline chloride | Adenine | N,N-Dicyclohexylcarbodiimide | Propoxur | Adiphenine hydrochloride | Ribavirin |
| 相关库 | Inhibitor Library | Anti-Parkinson's Disease Compound Library | Bioactive Compound Library | Bioactive Compounds Library Max | Anti-Viral Compound Library | FDA-Approved Drug Library | Membrane Protein-targeted Compound Library | Anti-Neurodegenerative Disease Compound Library | Drug Repurposing Compound Library | Pediatric Drug Library | Human Metabolite Library | NMPA-Approved Drug Library |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验to 100ng/ul. 5ul PCR reaction buffer with MgCl2 (15mM) 0.75ul Ol 1506 (25uM) 0.75ul Ol 1507 (25uM) 0.75ul Ol 1508 (25uM) 0.5 ul Amplitaq Gold 1.0 ul of each dNTP 34.25 ul of distilled, deionized
sp licin g , and prom oter activity following tran sfer to protoplastsby electroporation. Plant Mol. Biol. 1 8 , 6 75-689. 4 5. Q iu , S . , A d em a, C. M. an d L an e, T. (2 0 0 5 ) A com putational study of
Using ProHits to Store, Annotate, and Analyze Affinity Purification–Mass Spectrometry (AP‐MS) Data
for identifying proteins by tandem mass spectrometry. Anal. Chem. 75:4646‐4658. Orchard, S., Salwinski, L., Kerrien, S., Montecchi‐Palazzi, L., Oesterheld, M., Stumpflen, V., Ceol
技术资料暂无技术资料 索取技术资料
